The OTC derivatives regime in the SFO, and how far it is examinable

The over-the-counter derivatives regime is the newest significant addition to the Ordinance and it shows. Part IIIA was inserted rather than designed in, the obligations sit mostly in rules made under it, and two of the thirteen regulated activity types exist for it without yet being fully in operation for licensing. It is a genuinely awkward corner of the syllabus, and knowing how little of it is examinable is half the value of reading about it.

What the regime is for

OTC derivatives are bilateral contracts. Nobody outside the two parties necessarily knows they exist, which is precisely the problem regulators worldwide set out to fix after the financial crisis. The international response had a consistent shape, and Hong Kong's version follows it.

OTC Clear, an HKEX subsidiary, is the central counterparty for over-the-counter derivatives in Hong Kong. That is the one operational name worth carrying, and it connects this Part back to the HKEX group structure.

Types 11 and 12

Two regulated activity types were added for this regime. Type 11 is dealing in OTC derivative products. Type 12 is providing client clearing services for OTC derivative transactions. Both are on the statutory list of thirteen, and both have had their commencement for licensing purposes deferred, which is a state of affairs that has persisted long enough to become an exam fact in its own right.

For the full list and what each type permits, see the thirteen regulated activity types.

Where the detail lives

As with Part VI, Part IIIA is largely a framework. The specifics of which transactions must be reported, which must be cleared, who is caught and what the exemptions are all sit in rules made under the Ordinance rather than in the Part itself. That is why the syllabus lists OTC derivative reporting and clearing under Topic 4, alongside the other subsidiary legislation, as well as touching the Part under Topic 3.

The practical consequence for a candidate is that you are being asked about two different things under two different headings, and neither of them requires you to know the mechanics of a swap.

What Paper 1 actually asks

Very little, and at a high level. In our experience the examinable content amounts to the existence of a reporting and clearing regime, the identity of the central counterparty, the two regulated activity types, and the fact that the detail sits in subsidiary legislation. Nothing about product mechanics. Nothing about margin models.

The opinion: this is background reading, and it is the clearest case of it in Topic 3. If your study time is short, learn the four-row table above and the two type numbers, then leave it. A candidate who can name OTC Clear and knows that reporting and clearing are the two pillars has extracted essentially everything the paper is likely to want.

The concession: derivatives professionals will find that description almost insultingly thin, and they are right that it is. The regime is substantial, technical and consequential, and it governs a large market. Paper 1 is a fundamentals paper for people entering the industry, and it samples this subject at the level of does this candidate know the regime exists and roughly what it does. Deeper knowledge belongs to a specialist paper.

The five things worth remembering

1. Part IIIA of the Ordinance covers over-the-counter derivative transactions.
2. The two pillars are mandatory reporting to a trade repository and mandatory clearing through a central counterparty.
3. OTC Clear is the Hong Kong central counterparty and is part of the HKEX group.
4. Type 11 is dealing in OTC derivative products; Type 12 is providing client clearing services for them.
5. The detailed obligations sit in rules made under the Ordinance, examined under Topic 4.

If you are working through Topic 3 in order, the natural companions to this page are the SFO structure explained and Part IV on offers of investments, which is the other Part that sits early in the statute and is easy to skip.